University of Twente Student Theses

Login

Budget impact of treatment with daprodustat compared to the current standard of care for adult patients with anemia in chronic kidney disease stage III to V in The Netherlands

Jansen, C. (2023) Budget impact of treatment with daprodustat compared to the current standard of care for adult patients with anemia in chronic kidney disease stage III to V in The Netherlands.

Full text not available from this repository.

Full Text Status:Access to this publication is restricted
Embargo date:13 July 2028
Abstract:For the treatment of patients with anemia in chronic kidney disease (CKD) a new drug class, hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors (PHI) recently entered the Dutch healthcare market. In this study the budget impact as a result of the implementation of daprodustat (Jesduvroq), an oral drug belonging to this class, compared to the current standard of care (SoC) in adult patients with anemia from CKD stages III to V in The Netherlands is analyzed.
Item Type:Essay (Master)
Clients:
GSK, Amersfoort, Netherlands
Faculty:TNW: Science and Technology
Subject:44 medicine, 83 economics
Programme:Health Sciences MSc (66851)
Link to this item:https://purl.utwente.nl/essays/96212
Export this item as:BibTeX
EndNote
HTML Citation
Reference Manager

 

Repository Staff Only: item control page